Aripiprazole Long-acting Injectable Two-injection Start to Manage Supersensitivity Psychosis: A Case Report
Clinical Psychopharmacology and Neuroscience · 30.11.2025 · 23 (4) · 724-727
DOI: 10.9758/cpn.25.1284 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 21.04.2025. Verfasst von Hazal Yavuzlar Civan. Beteiligte Einrichtung: Department of Psychiatry, Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey.
ORCID-Profile: Hazal Yavuzlar Civan
Zitieren
APA
Civan, H. Y. (2025). Aripiprazole Long-acting Injectable Two-injection Start to Manage Supersensitivity Psychosis: A Case Report. Clinical Psychopharmacology and Neuroscience, 23(4), 724-727. https://doi.org/10.9758/cpn.25.1284
Vancouver
Civan HY. Aripiprazole Long-acting Injectable Two-injection Start to Manage Supersensitivity Psychosis: A Case Report. Clinical Psychopharmacology and Neuroscience. 2025;23(4):724-727. doi:10.9758/cpn.25.1284
BibTeX
@article{Civan2025,
author = {Civan, Hazal Yavuzlar},
title = {Aripiprazole Long-acting Injectable Two-injection Start to Manage Supersensitivity Psychosis: A Case Report},
journal = {Clinical Psychopharmacology and Neuroscience},
year = {2025},
volume = {23},
number = {4},
pages = {724--727},
doi = {10.9758/cpn.25.1284}
}
EUVIMED